Award
NIH Reporter #11165747
Hydrogen Sulfide for the Prevention of Cisplatin-Induced Atherosclerosis
Recipient
Virginia Commonwealth University
Award Amount
$46,494.00
Ceiling
$46,494.00
Awarded
August 14, 2025
Identifier
11165747
NIH grant awarded to Virginia Commonwealth University for research on preventing cisplatin-induced atherosclerosis using hydrogen sulfide, led by PI Nigeste Mariam Carter, with a funding amount of $46,494.
Description
This is a NIH grant project titled "Hydrogen Sulfide for the Prevention of Cisplatin-Induced Atherosclerosis" with an award amount of $46,494. The project focuses on studying the molecular mechanisms of cisplatin-induced atherosclerosis and evaluating the therapeutic potential of hydrogen sulfide (H2S). The principal investigator is Nigeste Mariam Carter from Virginia Commonwealth University. The project aims to assess necroptosis in macrophage foam cells and plaque vulnerability in a mouse model.